This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Early phase study enrollment in Canadian children with cancer near end of life: A retrospective cohort study from Cancer in Young People in Canada.
Cancer · 2025
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency.
Nature medicine · 2022
Clinical impact of primary tumour 123ImIBG response to induction chemotherapy in children with high-risk neuroblastoma.
International journal of clinical oncology · 2022
Latest funding
- $545,625
OPTIMISE: Optimal precision therapies to customise care in childhood and adolescent cancer
CIHR · 2022 · Nominated PI
- $23,000,000
Canadian Pediatric Cancer Consortium
CIHR · 2022 · Co-investigator
- $956,250
Biological and translational implications of replication repair deficiency and hypermutation in human cancer
CIHR · 2017 · Co-investigator
6 publications.
Early phase study enrollment in Canadian children with cancer near end of life: A retrospective cohort study from Cancer in Young People in Canada.
Hasan F, Widger K, Punnett A, Rapoport A, Morgenstern D, Cohen-Gogo S, Revon-Rivière G, Abbott L, Guilcher GMT, Fernandez C, Truong TH, Deyell RJ, Sung L
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency.
Das A, Sudhaman S, Morgenstern D, Coblentz A, Chung J, Stone SC, Alsafwani N, Liu ZA, Karsaneh OAA, Soleimani S, Ladany H, Chen D, Zatzman M, Cabric V, Nobre L, Bianchi V, Edwards M, Sambira Nahum LC, Ercan AB, Nabbi A, Constantini S, Dvir R, Yalon-Oren M, Campino GA, Caspi S, Larouche V, Reddy A, Osborn M, Mason G, Lindhorst S, Bronsema A, Magimairajan V, Opocher E, De Mola RL, Sabel M, Frojd C, Sumerauer D, Samuel D, Cole K, Chiaravalli S, Massimino M, Tomboc P, Ziegler DS, George B, Van Damme A, Hijiya N, Gass D, McGee RB, Mordechai O, Bowers DC, Laetsch TW, Lossos A, Blumenthal DT, Sarosiek T, Yen LY, Knipstein J, Bendel A, Hoffman LM, Luna-Fineman S, Zimmermann S, Scheers I, Nichols KE, Zapotocky M, Hansford JR, Maris JM, Dirks P, Taylor MD, Kulkarni AV, Shroff M, Tsang DS, Villani A, Xu W, Aronson M, Durno C, Shlien A, Malkin D, Getz G, Maruvka YE, Ohashi PS, Hawkins C, Pugh TJ, Bouffet E, Tabori U
Clinical impact of primary tumour 123ImIBG response to induction chemotherapy in children with high-risk neuroblastoma.
Szychot E, Morgenstern D, Chopra M, Sorrentino S, Arthurs O, Sebire N, Arfeen F, Brodkiewicz A, Humphries P, Biassoni L
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project.
Moreno L, Guo D, Irwin MS, Berthold F, Hogarty M, Kamijo T, Morgenstern D, Pasqualini C, Ash S, Potschger U, Ladenstein R, Valteau-Couanet D, Cohn SL, Pearson ADJ, London WB
Phase I dose-finding study for melatonin in pediatric oncology patients with relapsed solid tumors.
Johnston DL, Zupanec S, Nicksy D, Morgenstern D, Narendran A, Deyell RJ, Samson Y, Wu B, Baruchel S
Persisting inequalities in survival patterns of childhood neuroblastoma in Southern and Eastern Europe and the effect of socio-economic development compared with those of the US.
Panagopoulou P, Georgakis MK, Baka M, Moschovi M, Papadakis V, Polychronopoulou S, Kourti M, Hatzipantelis E, Stiakaki E, Dana H, Tragiannidis A, Bouka E, Antunes L, Bastos J, Coza D, Demetriou A, Agius D, Eser S, Gheorghiu R, Šekerija M, Trojanowski M, Žagar T, Zborovskaya A, Ryzhov A, Dessypris N, Morgenstern D, Petridou ET
OPTIMISE: Optimal precision therapies to customise care in childhood and adolescent cancer
Principal investigators: Morgenstern, Daniel A
Keywords: Early Phase Clinical Trials; Paediatric Oncology; Precision Medicine; Targeted Therapy
Canadian Pediatric Cancer Consortium
Principal investigators: David Malkin, James Whitlock; Co-Dyre, Adrienne; McIntosh, Keith A; Denburg, Avram E; Deyell, Rebecca J; Duval, Michel; Jabado, Nada; Marjerrison, Stacey L; Rayar, Meera; Tsimicalis, Argerie
Keywords: Cancer -Omics; Cancer Modeling; Clinical Trials; Community Engagement; Implementation Science; Innovative Therapies; Knowledge Mobilization; Pan-Canadian Consortium; Pediatric Cancer; Training And Mentorship
Biological and translational implications of replication repair deficiency and hypermutation in human cancer
Principal investigators: Tabori, Uri
Keywords: Animal Model; Cancer; Cancer Predisposrition; Hypermutation; Microsatelite Instability; Mismatch Repair Deficiency; Treatment
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Pediatrics
- Department of Laboratory Medicine and Pathobiology
- Department of Paediatrics
- Genetics and Genome Biology
- Pediatric Hematology/Oncology
- Biostatistics Division
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Aru Narendran
Pediatrics
1 shared papers, latest 2019
Uri Tabori
Genetics and Genome Biology
1 shared papers, latest 2022
Cynthia Hawkins
Department of Laboratory Medicine and Pathobiology
1 shared papers, latest 2022
David Malkin
Pediatrics
1 shared papers, latest 2022
Wei Xu
Biostatistics Division
1 shared papers, latest 2022
Lillian Sung
Faculty
1 shared papers, latest 2025
Kimberley Widger
Pediatrics
1 shared papers, latest 2025
Valérie Larouche
Pediatric Hematology/Oncology
1 shared papers, latest 2022
Adam Shlien
Faculty
1 shared papers, latest 2022
Eric Bouffet
Department of Paediatrics
1 shared papers, latest 2022
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.